Nanobodies®: New ammunition to battle viruses

Van den Abbeele, 2010, A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction, Cell. Mol. Life Sci., 67, 1519, 10.1007/s00018-010-0266-1

Barbas, 1992, Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro, Proc. Natl. Acad. Sci. USA, 89, 9339, 10.1073/pnas.89.19.9339

Beekwilder, 2008, Stable recombinant alpaca antibodies for detection of Tulip virus X, Eur. J. Plant Pathol., 121, 477, 10.1007/s10658-007-9265-y

Binley, 2004, Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies, J. Virol., 78, 13232, 10.1128/JVI.78.23.13232-13252.2004

Van Bockstaele, 2009, The development of nanobodies for therapeutic applications, Curr. Opin. Investig. Drugs, 10, 1212

Bouchet, 2011, Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody, Blood, 117, 3559, 10.1182/blood-2010-07-296749

Bruss, 2007, Hepatitis B virus morphogenesis, World J. Gastroenterol., 13, 65, 10.3748/wjg.v13.i1.65

Buchacher, 1994, Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization, AIDS Res. Hum. Retroviruses, 10, 359, 10.1089/aid.1994.10.359

Burns, 1996, Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity, Science, 272, 104, 10.1126/science.272.5258.104

Burton, 1991, A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals, Proc. Natl. Acad. Sci. USA, 88, 10134, 10.1073/pnas.88.22.10134

Burton, 1994, Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody, Science, 266, 1024, 10.1126/science.7973652

Calder, 2000, Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies, Virology, 271, 122, 10.1006/viro.2000.0279

Conrath, 2001, Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae, Antimicrob. Agents Chemother., 45, 2807, 10.1128/AAC.45.10.2807-2812.2001

Conrath, 2001, Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs, J. Biol. Chem., 276, 7346, 10.1074/jbc.M007734200

Conrath, 2009, Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase, Protein Sci., 18, 619, 10.1002/pro.69

Coppieters, 2006, Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis, Arthritis Rheum., 54, 1856, 10.1002/art.21827

Corthésy, 2006, Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion, J. Virol., 80, 10692, 10.1128/JVI.00927-06

Czauderna, 2000, Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells, J. Virol., 74, 4028, 10.1128/JVI.74.9.4028-4038.2000

Daelemans, 2005, Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo, Mol. Cell. Biol., 25, 728, 10.1128/MCB.25.2.728-739.2005

Dai, 2002, Targeted disruption of the alpha1, 3-galactosyltransferase gene in cloned pigs, Nat. Biotechnol., 20, 251, 10.1038/nbt0302-251

Daley, 2010, Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus, Clin. Vaccine Immunol., 17, 239, 10.1128/CVI.00421-09

Daley-Bauer, 2010, Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas, Clin. Vaccine Immunol., 17, 2007, 10.1128/CVI.00287-10

Dalgleish, 1984, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature, 312, 763, 10.1038/312763a0

Dekker, 2003, Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses, J. Virol., 77, 12132, 10.1128/JVI.77.22.12132-12139.2003

Deng, 2000, Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells, Transplantation, 70, 1010, 10.1097/00007890-200010150-00004

Denner, 2011, Infectious risk in xenotransplantation – what post-transplant screening for the human recipient?, Xenotransplantation, 18, 151, 10.1111/j.1399-3089.2011.00636.x

Deschacht, 2010, A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire, J. Immunol., 184, 5696, 10.4049/jimmunol.0903722

Desmyter, 2001, Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody, J. Biol. Chem., 276, 26285, 10.1074/jbc.M102107200

Desmyter, 1996, Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme, Nat. Struct. Biol., 3, 803, 10.1038/nsb0996-803

Dolk, 2005, Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo, Appl. Environ. Microbiol., 71, 442, 10.1128/AEM.71.1.442-450.2005

Dumoulin, 2002, Single-domain antibody fragments with high conformational stability, Protein Sci., 11, 500, 10.1110/ps.34602

Ewert, 2002, Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains, Biochemistry, 41, 3628, 10.1021/bi011239a

Falsey, 1995, Respiratory syncytial virus and influenza A infections in the hospitalized elderly, J. Infect. Dis., 172, 389, 10.1093/infdis/172.2.389

Feld, 2003, New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B, Hepatology, 38, 545, 10.1053/jhep.2003.50389

Fischer, 1995, The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs, Cell, 82, 475, 10.1016/0092-8674(95)90436-0

Fornerod, 1997, CRM1 is an export receptor for leucine-rich nuclear export signals, Cell, 90, 1051, 10.1016/S0092-8674(00)80371-2

Forsman, 2008, Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120, J. Virol., 82, 12069, 10.1128/JVI.01379-08

Foster, 2008, HIV-1 Nef: at the crossroads, Retrovirology, 5, 84, 10.1186/1742-4690-5-84

Fukuda, 1997, CRM1 is responsible for intracellular transport mediated by the nuclear export signal, Nature, 390, 308, 10.1038/36894

Garaicoechea, 2008, Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice, J. Virol., 82, 9753, 10.1128/JVI.00436-08

De Genst, 2006, Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, Proc. Natl. Acad. Sci. USA, 103, 4586, 10.1073/pnas.0505379103

Goldman, 2006, Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library, Anal. Chem., 78, 8245, 10.1021/ac0610053

Goudsmit, 2006, Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin, J. Infect. Dis, 193, 796, 10.1086/500470

Greenberg, 1996, A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks, Nature, 374, 168, 10.1038/374168a0

Groot, 2006, Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha, Lab. Invest., 86, 345, 10.1038/labinvest.3700395

Groothuis, 1993, Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The respiratory syncytial virus immune globulin study group, N. Engl. J. Med., 329, 1524, 10.1056/NEJM199311183292102

Gualtero, 2007, Amino acid domains 280–297 of VP6 and 531–554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection, Arch. Virol., 152, 2183, 10.1007/s00705-007-1055-5

De Haard, 2005, Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection, J. Bacteriol., 187, 4531, 10.1128/JB.187.13.4531-4541.2005

Hall, 2001, Respiratory syncytial virus and parainfluenza virus, N. Engl. J. Med., 344, 1917, 10.1056/NEJM200106213442507

Hall, 2009, The burden of respiratory syncytial virus infection in young children, N. Engl. J. Med., 360, 588, 10.1056/NEJMoa0804877

Hamers-Casterman, 1993, Naturally occurring antibodies devoid of light chains, Nature, 363, 446, 10.1038/363446a0

Hanna, 1998, Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice, Cell, 95, 163, 10.1016/S0092-8674(00)81748-1

Harmsen, 2007, Properties, production, and applications of camelid single-domain antibody fragments, Appl. Microbiol. Biotechnol., 77, 13, 10.1007/s00253-007-1142-2

Harmsen, 2000, Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features, Mol. Immunol., 37, 579, 10.1016/S0161-5890(00)00081-X

Harmsen, 2005, Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins, Vaccine, 23, 4926, 10.1016/j.vaccine.2005.05.017

Harmsen, 2006, Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy, Appl. Microbiol. Biotechnol., 72, 544, 10.1007/s00253-005-0300-7

Harmsen, 2007, Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease, Vet. Microbiol., 120, 193, 10.1016/j.vetmic.2006.10.029

Harmsen, 2008, Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin, Vet. Microbiol., 132, 56, 10.1016/j.vetmic.2008.04.030

Harmsen, 2009, Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation, Appl. Microbiol. Biotechnol., 84, 1087, 10.1007/s00253-009-2029-1

Harmsen, 2009, Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs, Vaccine, 27, 1904, 10.1016/j.vaccine.2009.01.110

Hemming, 1985, Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model, J. Infect. Dis., 152, 1083, 10.1093/infdis/152.5.1083

Henderson, 1979, Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children, N. Engl. J. Med, 300, 530, 10.1056/NEJM197903083001004

Hilleman, 2003, Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus, Vaccine, 21, 4626, 10.1016/S0264-410X(03)00529-2

Hinz, 2010, Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction, PLoS ONE, 5, e10482, 10.1371/journal.pone.0010482

Hmila, 2010, A bispecific Nanobody to provide full protection against lethal scorpion envenoming, FASEB J., 24, 3479, 10.1096/fj.09-148213

Holliger, 2005, Engineered antibody fragments and the rise of single domains, Nat. Biotechnol., 23, 1126, 10.1038/nbt1142

Hultberg, 2011, Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules, PLoS ONE, 6, e17665, 10.1371/journal.pone.0017665

Hultberg, 2007, Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages, BMC Biotechnol., 7, 58, 10.1186/1472-6750-7-58

Ibañez, 2011, Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection, J. Infect. Dis., 203, 1063, 10.1093/infdis/jiq168

Jähnichen, 2010, CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells, Proc. Natl. Acad. Sci. USA, 107, 20565, 10.1073/pnas.1012865107

Johnson, 1997, Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus, J. Infect. Dis., 176, 1215, 10.1086/514115

Kann, 2007, Intracellular transport of hepatitis B virus, World J. Gastroenterol., 13, 39, 10.3748/wjg.v13.i1.39

Klatzmann, 1984, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature, 312, 767, 10.1038/312767a0

Klooster, 2009, Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression, J. Immunol. Methods, 342, 1, 10.1016/j.jim.2008.10.009

Knobel, 2005, Re-evaluating the burden of rabies in Africa and Asia, Bull. World Health Organ., 83, 360

Koh, 2010, Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1, J. Biol. Chem., 285, 19116, 10.1074/jbc.M110.116699

Kolkman, 2010, Nanobodies-from llamas to therapeutic proteins, Drug Discov. Today: Technol., 7, e139, 10.1016/j.ddtec.2010.03.002

van der Laan, 2000, Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice, Nature, 407, 90, 10.1038/35024089

Lai, 2002, Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning, Science, 295, 1089, 10.1126/science.1068228

Lauwereys, 1998, Potent enzyme inhibitors derived from dromedary heavy-chain antibodies, EMBO J., 17, 3512, 10.1093/emboj/17.13.3512

Lavanchy, 2005, Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention, J. Clin. Virol, 34, S1, 10.1016/S1386-6532(05)00384-7

Lavanchy, 2008, Chronic viral hepatitis as a public health issue in the world, Best. Pract. Res. Clin. Gastroenterol., 22, 991, 10.1016/j.bpg.2008.11.002

Ledeboer, 2002, Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama, J. Dairy Sci., 85, 1376, 10.3168/jds.S0022-0302(02)74204-5

van der Linden, 1999, Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies, Biochim. Biophys. Acta, 1431, 37, 10.1016/S0167-4838(99)00030-8

Mai, 2006, ES1, a new lung carcinoma antibody – an immunohistochemical study, Histopathology, 49, 515, 10.1111/j.1365-2559.2006.02539.x

Malim, 1989, The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA, Nature, 338, 254, 10.1038/338254a0

Martín, 2011, Integrative expression system for delivery of antibody fragments by lactobacilli, Appl. Environ. Microbiol., 77, 2174, 10.1128/AEM.02690-10

Moineau, 1999, Applications of phage resistance in lactic acid bacteria, Antonie Van Leeuwenhoek, 76, 377, 10.1023/A:1002045701064

Moore, 1997, Co-receptors for HIV-1 entry, Curr. Opin. Immunol., 9, 551, 10.1016/S0952-7915(97)80110-0

Moulard, 2002, Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120–CD4–CCR5 complexes, Proc. Natl. Acad. Sci. USA, 99, 6913, 10.1073/pnas.102562599

Muhamuda, 2007, Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies, Hum. Vaccine, 3, 192, 10.4161/hv.3.5.4386

Müller, 2009, Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans, PLoS Negl. Trop. Dis., 3, e542, 10.1371/journal.pntd.0000542

Muyldermans, 1994, Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains, Protein Eng., 7, 1129, 10.1093/protein/7.9.1129

Muyldermans, 2001, Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains, Trends Biochem. Sci., 26, 230, 10.1016/S0968-0004(01)01790-X

Muyldermans, 2009, Camelid immunoglobulins and nanobody technology, Vet. Immunol. Immunopathol., 128, 178, 10.1016/j.vetimm.2008.10.299

Neville, 1997, The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export, Curr. Biol., 7, 767, 10.1016/S0960-9822(06)00335-6

Nguyen, 1999, Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies, Mol. Immunol., 36, 515, 10.1016/S0161-5890(99)00067-X

Nguyen, 2000, Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire, EMBO J., 19, 921, 10.1093/emboj/19.5.921

Nuttall, 2001, Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries, Mol. Immunol., 38, 313, 10.1016/S0161-5890(01)00057-8

Pant, 2006, Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea, J. Infect. Dis., 194, 1580, 10.1086/508747

Paradis, 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group, Science, 285, 1236, 10.1126/science.285.5431.1236

Parashar, 2006, Rotavirus and severe childhood diarrhea, Emerging Infect. Dis., 12, 304, 10.3201/eid1202.050006

Patience, 1997, Infection of human cells by an endogenous retrovirus of pigs, Nat. Med., 3, 282, 10.1038/nm0397-282

Patience, 2001, Multiple groups of novel retroviral genomes in pigs and related species, J. Virol., 75, 2771, 10.1128/JVI.75.6.2771-2775.2001

Pérez, 2001, Thermal unfolding of a llama antibody fragment: a two-state reversible process, Biochemistry, 40, 74, 10.1021/bi0009082

Peterson, 2004, Ecologic and geographic distribution of filovirus disease, Emerging Infect. Dis., 10, 40, 10.3201/eid1001.030125

Phelps, 2003, Production of alpha 1,3-galactosyltransferase-deficient pigs, Science, 299, 411, 10.1126/science.1078942

Platt, 2002, Knocking out xenograft rejection, Nat. Biotechnol., 20, 231, 10.1038/nbt0302-231

Pollard, 1998, The HIV-1 Rev protein, Annu. Rev. Microbiol., 52, 491, 10.1146/annurev.micro.52.1.491

Prince, 1985, Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat, Virus Res., 3, 193, 10.1016/0168-1702(85)90045-0

Rabe, 2003, Nuclear import of hepatitis B virus capsids and release of the viral genome, Proc. Natl. Acad. Sci. USA, 100, 9849, 10.1073/pnas.1730940100

Roben, 1994, Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1, J. Virol., 68, 4821, 10.1128/JVI.68.8.4821-4828.1994

Roovers, 2007, Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies, Cancer Immunol. Immunother., 56, 303, 10.1007/s00262-006-0180-4

Russell, 2008, The global circulation of seasonal influenza A (H3N2) viruses, Science, 320, 340, 10.1126/science.1154137

Sanders, 2002, The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120, J. Virol., 76, 7293, 10.1128/JVI.76.14.7293-7305.2002

Sarker, 2001, Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea, J. Pediatr. Gastroenterol. Nutr., 32, 19, 10.1097/00005176-200101000-00009

Sawyer, 2000, Antibodies for the prevention and treatment of viral diseases, Antiviral Res., 47, 57, 10.1016/S0166-3542(00)00111-X

Serruys, 2010, Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies, J. Gen. Virol., 91, 643, 10.1099/vir.0.016063-0

Serruys, 2009, Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice, Hepatology, 49, 39, 10.1002/hep.22609

Sherwood, 2007, Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4, J. Infect. Dis., 196, S213, 10.1086/520586

Simoes, 1996, Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children, J. Pediatr., 129, 214, 10.1016/S0022-3476(96)70245-7

Specke, 2001, Productive infection of human primary cells and cell lines with porcine endogenous retroviruses, Virology, 285, 177, 10.1006/viro.2001.0934

Spinelli, 2006, Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses, Nat. Struct. Mol. Biol., 13, 85, 10.1038/nsmb1029

Stewart, 2007, Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development, Toxicon, 49, 699, 10.1016/j.toxicon.2006.11.023

Stijlemans, 2011, High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis, PLoS Pathog., 7, e1002072, 10.1371/journal.ppat.1002072

Stijlemans, 2004, Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm, J. Biol. Chem., 279, 1256, 10.1074/jbc.M307341200

Stone, 2007, A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1, Mol. Immunol., 44, 2487, 10.1016/j.molimm.2006.10.020

Stone, 2007, The assembly of single domain antibodies into bispecific decavalent molecules, J. Immunol. Methods, 318, 88, 10.1016/j.jim.2006.10.006

Takeuchi, 1998, Host range and interference studies of three classes of pig endogenous retrovirus, J. Virol., 72, 9986, 10.1128/JVI.72.12.9986-9991.1998

Taylor, 1984, Monoclonal antibodies protect against respiratory syncytial virus infection in mice, Immunology, 52, 137

Thys, 2011, A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads, J. Virol. Methods, 173, 300, 10.1016/j.jviromet.2011.02.023

Thys, 2010, In vitro antiviral activity of single domain antibody fragments against poliovirus, Antiviral Res., 87, 257, 10.1016/j.antiviral.2010.05.012

Tijink, 2008, Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology, Mol. Cancer Ther., 7, 2288, 10.1158/1535-7163.MCT-07-2384

Le Tissier, 1997, Two sets of human-tropic pig retrovirus, Nature, 389, 681, 10.1038/39489

Transue, 1998, Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate, Proteins, 32, 515, 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E

Tremblay, 2006, Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site, J. Bacteriol., 188, 2400, 10.1128/JB.188.7.2400-2410.2006

Trkola, 1996, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J. Virol., 70, 1100, 10.1128/JVI.70.2.1100-1108.1996

van der Vaart, 2006, Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments, Vaccine, 24, 4130, 10.1016/j.vaccine.2006.02.045

Vercruysse, 2010, An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production, J. Biol. Chem., 285, 21768, 10.1074/jbc.M110.112490

Vercruysse, 2011, Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer, RNA Biol., 8, 316, 10.4161/rna.8.2.13782

Verheesen, 2006, Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation, Biochim. Biophys. Acta, 1764, 1307, 10.1016/j.bbapap.2006.05.011

Vincke, 2009, General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold, J. Biol. Chem., 284, 3273, 10.1074/jbc.M806889200

Vu, 1997, Comparison of llama VH sequences from conventional and heavy chain antibodies, Mol. Immunol., 34, 1121, 10.1016/S0161-5890(97)00146-6

Walsh, 1984, Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies, Infect. Immun., 43, 756, 10.1128/IAI.43.2.756-758.1984

Ward, 2009, Mechanisms of protection against rotavirus infection and disease, Pediatr. Infect. Dis. J., 28, S57, 10.1097/INF.0b013e3181967c16

Wassilak, 2010, Challenges faced by the global polio eradication initiative, Expert. Rev. Vaccines, 9, 447, 10.1586/erv.10.45

Wesolowski, 2009, Single domain antibodies: promising experimental and therapeutic tools in infection and immunity, Med. Microbiol. Immunol., 198, 157, 10.1007/s00430-009-0116-7

Woolven, 1999, The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation, Immunogenetics, 50, 98, 10.1007/s002510050694

Wu, 2008, Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab, Curr. Top. Microbiol. Immunol., 317, 103

Wyatt, 1998, The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens, Science, 280, 1884, 10.1126/science.280.5371.1884

Xu, 2003, Molecular therapeutics of HBV, Curr. Gene Ther., 3, 341, 10.2174/1566523034578294

Yang, 2002, Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection, Proc. Natl. Acad. Sci. USA, 99, 13825, 10.1073/pnas.202398599

Zhang, 2004, Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents, J. Mol. Biol., 335, 49, 10.1016/j.jmb.2003.09.034

Zhou, 2007, Structural definition of a conserved neutralization epitope on HIV-1 gp120, Nature, 445, 732, 10.1038/nature05580

Zoulim, 2011, Hepatitis B virus resistance to antiviral drugs: where are we going?, Liver. Int., 31, 111, 10.1111/j.1478-3231.2010.02399.x